ITIH4 and neoplasm: Consistent with this, our experience is that several different viral and tumour antigens can be inserted into the C-terminal end of the vaccine format, with maintenance of expression and secretion (for example, gp120 and hemagglutinin (data not shown), scFv315 and scFvA20 and fragment C of tetanus toxin [14, 16, 17]).